NHS National Pharmaceuticals Dasatinib and Paliperidone Injection

NHS England · Awarded

Buyer
NHS England
Status
Awarded
Country
United Kingdom
Region
England
Sector
Manufacturing
Reference
FaT-ocds-h6vhtk-03981f
Published
2023-04-27
Deadline
2026-04-21

Tender summary

Proposed framework agreement for NHS National Generic Pharmaceuticals Dasatinib and Paliperidone Injection. Offer reference number: CM/PHG/22/5694 Potential periods of call-offs under the framework agreement: CM/PHG/22/5694/00 - Dasatinib CESW 01/05/2023 – 30/04/2024 – (12 Months) LSNE 01/05/2023 – 30/04/2024 – (12 Months) NWLN 01/05/2023 – 30/04/2024 – (12 Months) CM/PHG/22/5694/01 - Paliperidone Injection: LSNE 01/05/2023 – 31/05/2024 (13 Months) NWLN 01/05/2023 – 31/01/2025 (21 months)

This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.

Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.

Register for full access

IT tenders · Construction tenders · Sitemap